One such therapy in particular, that is, anti-programmed cell death protein 1 (PD-1)/programmed death-ligand 1 (PD-L1) antibody therapy has been widely applied to treat several types of cancer [84, 85]. The gene discussed is PDCD1; the disease is cancer.